SRH Advisors’s bluebird bio BLUE Stock Holding History

SRH Advisors’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1	Closed	-$25	–	308
2023 Q4	$25	Hold	1	–	–	﹤0.01%	297
2023 Q3	$55	Hold	1	–	–	﹤0.01%	289
2023 Q2	$57	Hold	1	–	–	﹤0.01%	293
2023 Q1	$0	Hold	1	–	–	﹤0.01%	288
2022 Q4	$0	Hold	1	–	–	﹤0.01%	297
2022 Q3	$0	Hold	1	–	–	﹤0.01%	312
2022 Q2	$0	Hold	1	–	–	﹤0.01%	299
2022 Q1	$0	Hold	1	–	–	﹤0.01%	308
2021 Q4	$0	Hold	1	–	–	﹤0.01%	307
2021 Q3	$0	Hold	1	–	–	﹤0.01%	305
2021 Q2	$1K	Hold	1	–	–	﹤0.01%	294
2021 Q1	$1K	Hold	1	–	–	﹤0.01%	290
2020 Q4	$1K	Hold	1	–	–	﹤0.01%	288
2020 Q3	$1K	Hold	1	–	–	﹤0.01%	284
2020 Q2	$1K	Hold	1	–	–	﹤0.01%	266
2020 Q1	$1K	Hold	1	–	–	﹤0.01%	257
2019 Q4	$2K	Hold	1	–	–	0.01%	234
2019 Q3	$2K	Hold	1	–	–	0.01%	239
2019 Q2	$2K	Hold	1	–	–	0.01%	241
2019 Q1	$3K	Buy	+1	New	+$1.76K	0.01%	220

Other funds holding BLUE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

SRH Advisors's BLUE Position: Q1 2024 in Review

SRH Advisors sold out of bluebird bio (BLUE) in Q1 2024, closing a stake of 1 share — an estimated $25 sold.

SRH Advisors first reported a position in BLUE in Q1 2019 and held it in 20 quarters. The position peaked at $3K in Q1 2019. 158 funds tracked by Wall St. Rank hold BLUE as of Q1 2024.

SRH Advisors reported no remaining bluebird bio position as of Q1 2024 after selling out during the quarter.
SRH Advisors sold 1 bluebird bio share in Q1 2024, an estimated $25.
SRH Advisors first reported a position in bluebird bio in Q1 2019 and held it in 20 quarters.
SRH Advisors's bluebird bio position peaked at $3K in Q1 2019.
158 funds tracked by Wall St. Rank held bluebird bio as of Q1 2024.

Based on SRH Advisors's 13F filing for Q1 2024, filed 26 Apr 2024.